US 7671071
Polymorphic Form XVI of fexofenadine hydrochloride
granted A61PA61P11/06A61P17/04
Quick answer
US patent 7671071 (Polymorphic Form XVI of fexofenadine hydrochloride) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Feb 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Tue Mar 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61P, A61P11/06, A61P17/04, A61P29/00, A61P37/08